Dana-Farber/Boston Children's Cancer and Blood Disorders Center
In research, Dana-Farber/Boston Children's Cancer and Blood Disorders Center stands highest in Medicine (#5,407 of 10,443 worldwide) and Health Sciences (#7,133 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #8,080 of 28,054 · #2,411 all time
- Rank in United States
- #1,074 of 4,192
- Research works
- 1k ▲ 74% vs 2013–17
- Citations
- 78k 75.8 per fractional work
- Top-10% rate
- 22.5% record average 16.5%
- Open access
- 50% world 28%
What is Dana-Farber/Boston Children's Cancer and Blood Disorders Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,407 of 10,443 | 21.0% | 114 | #995 | |
| Health SciencesDomain | #7,133 of 11,982 | 20.8% | 117 | #1346 |
Each strip is that field’s whole ranked pool, with the notch where Dana-Farber/Boston Children's Cancer and Blood Disorders Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.6×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.6×
- Immunology and Microbiology 4.3×
- Medicine 3.3×
- Neuroscience 1.0×
- Mathematics 0.6×
- Health Professions 0.5×
- Nursing 0.5×
- Decision Sciences 0.3×
- Economics, Econometrics and Finance 0.2×
- Psychology 0.2×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Dentistry 0.1×
- Chemistry 0.1×
- Materials Science 0.1×
- Computer Science 0.0×
- Engineering 0.0×
- Environmental Science 0.0×
- Energy 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center?
Ranked on the composite score, Steven G. DuBois, Emily Harris and Rachael F. Grace lead among researchers whose main affiliation is Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
- 1 Steven G. DuBois United States · #358,767 worldwide 110 citations · 45 works
- 2 Emily Harris United States · #543,182 worldwide 39 citations · 24 works
- 3 Rachael F. Grace United States · #1,336,255 worldwide 27 citations · 26 works
Which keywords describe research at Dana-Farber/Boston Children's Cancer and Blood Disorders Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Genetic Mutations, Prognostic Factors, Radiotherapy, Molecular Classification, Glioblastoma, Temozolomide and Inflammation.
- Vascular Biology
- Antithrombotic Therapy
- Minimal Residual Disease
- Anemia
- Thalassemia
- Transcriptional Regulation
- Targeted Therapy
- Thrombosis
- Clinical Trials
- Pediatric Quality of Life Inventory
- Childhood Cancer Survivor Study
- Health-related Quality of Life
- ALK
- Prognosis
- Hematopoietic Stem Cells
- Epidemiology
- Glioblastoma
- Cancer
- Inflammation
- Genetic Mutations
- Immunotherapy
- Prognostic Factors
- Radiotherapy
- Molecular Classification
- Temozolomide
- Chemotherapy
- Therapy
- Staging System
- Neuroblastoma
- Clinical Practice Guidelines
- Hemostasis
- Diagnosis
- Apoptosis
- Pulmonary Hypertension
- Tumor Microenvironment
- Sickle-cell Disease
- Genetic Variants
- Erythropoiesis
- Pancreatic Cancer
- Platelets
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy22▲ 17×11 topics
- Genetic Mutations17▲ 22×21 topics
- Prognostic Factors16▲ 20×14 topics
- Inflammation14▲ 3.6×36 topics
- Radiotherapy12▲ 17×10 topics
- Cancer12▲ 4.8×33 topics
- Molecular Classification11▲ 40×4 topics
- Glioblastoma10▲ 82×1 topic
- Temozolomide10▲ 82×1 topic
- Epidemiology10▲ 1.39×40 topics
- Chemotherapy10▲ 7.6×19 topics
- Hematopoietic Stem Cells9▲ 58×3 topics
- Therapy7▲ 20×3 topics
- Prognosis7▲ 11×5 topics
- Staging System7▲ 62×2 topics
- ALK7▲ 142×1 topic
- Neuroblastoma7▲ 142×1 topic
- Health-related Quality of Life6▲ 15×3 topics
- Clinical Practice Guidelines6▲ 5.9×8 topics
- Childhood Cancer Survivor Study6▲ 70×1 topic
- Hemostasis6▲ 33×3 topics
- Pediatric Quality of Life Inventory6▲ 70×1 topic
- Diagnosis6▲ 3.2×18 topics
- Clinical Trials5▲ 4.4×11 topics
- Apoptosis5▲ 8.9×13 topics
- Thrombosis5▲ 9.7×6 topics
- Pulmonary Hypertension5▲ 19×2 topics
- Targeted Therapy5▲ 12×5 topics
- Tumor Microenvironment5▲ 5.8×8 topics
- Transcriptional Regulation4▲ 16×7 topics
- Sickle-cell Disease4▲ 57×1 topic
- Thalassemia4▲ 57×1 topic
- Genetic Variants4▲ 14×4 topics
- Anemia4▲ 23×4 topics
- Erythropoiesis4▲ 35×2 topics
- Minimal Residual Disease4▲ 29×2 topics
- Pancreatic Cancer4▲ 19×3 topics
- Antithrombotic Therapy4▲ 25×2 topics
- Platelets4▲ 28×2 topics
- Vascular Biology4▲ 45×2 topics
Which research topics does Dana-Farber/Boston Children's Cancer and Blood Disorders Center publish most on?
By volume in 2022–2025: Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Childhood Cancer Survivors' Quality of Life and Hemoglobinopathies and Related Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Glioma Diagnosis and Treatment Genetics 10 works
- 2 Neuroblastoma Research and Treatments Neurology 7 works
- 3 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 6 works
- 4 Hemoglobinopathies and Related Disorders Genetics 4 works
- 5 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 4 works
- 6 Blood disorders and treatments Genetics 3 works
- 7 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 8 Acute Myeloid Leukemia Research Hematology 3 works
- 9 Platelet Disorders and Treatments Hematology 3 works
- 10 Erythrocyte Function and Pathophysiology Physiology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dana-Farber/Boston Children's Cancer and Blood Disorders Center's research output changed?
Output in 2018–2022 was 74% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.